Hepatocellular carcinoma

37,739views

Hepatocellular carcinoma

Watch later

Watch later

Inflammatory bowel disease: Clinical
Diverticular disease: Clinical
Peptic ulcers and stomach cancer: Clinical
Burns: Clinical
Neck trauma: Clinical
Hernias: Clinical
Abdominal trauma: Clinical
Chest trauma: Clinical
Pediatric gastrointestinal bleeding: Clinical
Pediatric vomiting: Clinical
Pediatric constipation: Clinical
Fats and lipids
Gastric cancer
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Hepatocellular carcinoma
Vasculitis: Pathology review
Vasculitis: Clinical
Nephroblastoma (Wilms tumor)
Renal artery stenosis
Peripheral artery disease
Peripheral artery disease: Pathology review
Placental abruption
Thrombosis syndromes (hypercoagulability): Pathology review
Dilated cardiomyopathy
Perinatal infections: Clinical
Complications during pregnancy: Pathology review
Ectopic pregnancy
Antiplatelet medications
Blood products and transfusion: Clinical
Hemolytic-uremic syndrome
Platelet disorders: Pathology review
Immune thrombocytopenia
Thrombocytopenia: Clinical
Congenital pulmonary airway malformation
Two-sample t-test
Two-way ANOVA
Hypothesis testing: One-tailed and two-tailed tests
Paired t-test
Testosterone
Testing effect
Overcoming Test Anxiety
Test precision and accuracy
General anesthetics
Postoperative evaluation: Clinical
Malabsorption syndromes: Pathology review
Pituitary tumors: Pathology review
Hypothyroidism: Pathology review
Meniscus tear
Adrenal masses and tumors: Clinical
Adrenal insufficiency: Clinical
Adrenal masses: Pathology review
Adrenal insufficiency: Pathology review
Monoclonal antibodies

Flashcards

Hepatocellular carcinoma

0 of 8 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 1 complete

A 67-year-old man comes to the clinic due to worsening fatigue and abdominal distension. The patient has lost 11 pounds in the last 2 months with minimal change in appetite. Past medical history is notable for chronic liver disease due to hepatitis B infection that was diagnosed 15 years ago. His most recent colonoscopy 1 year ago showed no abnormalities. His temperature is 37.0°C (98.6°F), pulse is 85/min, and blood pressure is 154/89 mm Hg. Physical examination reveals temporal wasting and scleral icterus. Palmar erythema and multiple spider angiomas are present. The abdomen is distended with shifting dullness to percussion. There is 2+ pitting edema of the lower extremities. Ultrasound shows a single homogenous liver mass with irregular borders. Which of the following best describes the tumor marker that is likely elevated in this patient?

Transcript

Watch video only

Content Reviewers

As opposed to benign hepatic tumors, malignant hepatic tumors are cancerous, very severe, and are actually now the third leading cause of cancer deaths worldwide.

With these malignant liver cells or hepatocytes, just like malignant cells in other cancers, they develop some mutation that causes them to replicate at way higher rates and form these masses of cells that continue to grow and potentially spread to other tissues.

This would be a primary hepatic tumor, since it starts in the liver. It’s totally possible, though, for liver tumor to develop as a metastasis from another primary cancer, in which case it would not be hepatocellular carcinoma, but a carcinoma from somewhere else, and this is actually more common than primary liver tumors themselves.

The most common sources of the tumor cells that got to the liver but started somewhere else are the colon, pancreas, lung and breast.

What exactly causes the mutation in the hepatocyte though?

Well the mechanism isn’t fully understood and can probably be caused by a lot of different things, most importantly though, things that put the liver in a constant cycle of damage and repair are the biggest culprits.

If the liver cells are constantly being forced to repair, this raises the chances of genetic mistakes or mutations, potentially leading to carcinogenesis or development of cancer cells.

Examples might be any disease that leads to cirrhosis and scarring of the liver tissue, which can include alcoholic hepatitis and cirrhosis, hereditary hemochromatosis, primary biliary cirrhosis, alpha-1 antitrypsin deficiency, and others.

The most common risk factor, the ones that have been linked the most with hepatocellular carcinoma are the hepatitis B and hepatitis C viruses, both of which can become chronic or long-lasting.

In this case, these cells are at greater risk because of the constant state of infection and immune cell attack, leading to constant damage and repair.

HBV is particularly problematic because of how the virus replicates; the HBV virus is a DNA virus that integrates into the hepatocyte’s DNA, which, although not completely understood, is thought to either directly disrupt regulation of cell growth and replication, leading to carcinoma, or alternatively cause some indirect effect that later leads to unchecked cell growth and replication.

One interesting risk factor, is exposure to aflatoxins.

Aflatoxins are highly toxic chemicals produced by certain aspergillus molds that can be found in certain foods when they start to decay, like grains, peanuts, and vegetables.

As foods that have this type of mold are eaten, aflatoxins are also eaten, and then they’re absorbed in the small intestine and sent to the liver for metabolizing.

The most potent type of aflatoxin thought to be involved in carcinogenesis is aflatoxin B1, and when it gets to the liver, it’s metabolized to aflatoxin B1 8,9 epoxide.

And now this guy can bind right to DNA, called a DNA adduct.

This interaction leads to mutations in the p53 tumor suppressor gene, which usually when it’s functioning right, stops the formation of tumors, so if it becomes mutated and dysfunctional, tumor formation and carcinogenesis might follow.

Because most patients with hepatocellular carcinoma also have cirrhosis, the hepatocellular carcinoma can be hard to spot.